By Philip Scheltens MD PhD, Serge Gauthier, Philip Scheltens, Jeffrey L. Cummings
content material: Innervation of Senile Plaques: A hyperlink among Amyloid and Neurofibrillary Pathology? B. Delatour, V. Blanchard, L. Pradier, and C. Duyckaerts Vascular components and Alzheimer's sickness, I. Skoog, D. Gustafson, and M. Sjogren The function of White topic Lesions in Dementia, L. Pantoni Subclassification of gentle Cognitive Impairment in learn and scientific perform, S. Gauthier and J. Touchon Neuropsychiatric features of light Cognitive Impairment, T.J. Hung and J.L. Cummings Cognitive Rehabilitation in light Cognitive Impairment and Prodromal Alzheimer's affliction, M. van der Linden, A.-C. Juillerat, and X. Delbeuck medical Trial layout within the Age of Dementia remedies: demanding situations and possibilities, E. Mohr, C.L. Barclay, R. Anderson, and J. consistent Ethics of analysis in Dementia, J. Karlawish Memantine: A Glutamate Antagonist for therapy of Alzheimer's illness, R. Smith Doody, B. Winbald, and V. Jelic administration of Comorbidity in Alzheimer's illness, R. Jones dietary Prevention in Alzheimer's ailment, O. Guerin and B. Vellas Index
Read or Download Alzheimer's disease and related disorders annual. / 2004 PDF
Similar geriatrics books
This ebook locations major concerns on the topic of the health and wellbeing, psychological well-being, and wellbeing and fitness of older adults and their caregivers in the context of social paintings carrier supply. via featuring the learn of social paintings students, all specialists in particular learn components, the editors make clear the worth that social paintings brings to the bigger realm of well-being take care of older adults and their households.
This quantity brings jointly top researchers on caliber of lifestyles in outdated age to target essentially the most vital concerns in either gerontology and caliber of existence reports. There are only a few texts to be had in this subject and none of a global and multi-disciplinary nature. For those purposes and the top of the range of the authors now we have assembled, this may be a seminal textual content for either gerontology and caliber of lifestyles researchers.
Human immunosenescence contributes to morbidity and mortality in later existence. The age-associated expanding prevalence of melanoma and heart problems plateaus at round eighty years of age in industrialised nations, yet dying because of infectious disorder keeps to extend as much as a hundred years of age and past.
It is a entire, sensible, densely illustrated diagnostic and healing consultant for all geriatric dermatology companies. The publication contains 50 chapters and over six hundred colour photos on themes starting from universal stipulations reminiscent of basal telephone carcinoma, rosacea, and seborrheic dermatitis to strange stipulations similar to angiosarcoma, dermatofibrosarcoma protuberans, and porphyria cutanea tarda.
- Integrated Management of Depression in the Elderly
- Active Ageing, Active Learning: Issues and Challenges
- Dysphagia: Diagnosis and Treatment
- Persoonsgerichte zorg: Praktijken van goede zorg voor ouderen
Additional info for Alzheimer's disease and related disorders annual. / 2004
124. Wolozin B, Kellman W, Ruosseau P et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000; 57:1439–1443. 125. Rockwood K, Kirkland S, Hogan DB et al. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 2002; 59:223–227. 126. Simons M, Schwarzler F, Lutjohann D et al. Treatment with simvastatin in normocholesterolemic patients with Alzheimer’s disease: a 26-week randomized, placebo-controlled, double-blind trial.
Neurobiol Dis 2000; 7:321–331. 122. Refolo LM, Pappolla MA, LaFrancois J et al. A cholesterollowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer’s disease. Neurobiol Dis 2001; 8:890–899. 123. Jick H, Zornberg GL, Jick SS et al. Statins and the risk of dementia. Lancet 2000; 356: 1627–1631. 124. Wolozin B, Kellman W, Ruosseau P et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000; 57:1439–1443.
Richards SS, Emsley CL, Roberts J et al. The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans. J Am Geriatr Soc 2000; 48: 1035–1041. 94. in’t Veld BA, Ruitenberg A, Hofman A et al. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 2001; 22:407– 412. 95. Forette F, Seux M-L, Staessen J et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.